Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Chugai Pharmaceutical Co., Ltd. (CUP)
Market Closed
12 Jun, 20:00
XFRA
All
(8)
DE
(5)
JP
(1)
MX
(1)
US
(1)
JPX
Primary
OTC PINK
XHAN
XSTU
XDUS
XMUN
XFRA
XMEX
40.
12
+0.28
+0.7028%
74.04B
Market Cap
-
P/E Ratio
1.7%
Div Yield
175
Volume
-
Eps
39.84
Previous Close
Watching
Watch
Add Transaction
Day Range
39.83
40.54
Year Range
33.02
56.26
Want to track
CUP
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Chugai Pharmaceutical Co., Ltd. (CUP) Statistics
Valuation metrics
Market Cap
74.04B
Enterprise value
-4.7B
Trailing P/E (ttm)
31.69
Forward P/E
0.31
PEG ratio
1.25
Price/Sales (ttm)
0.06
Price/Book (mrq)
6.81
Enterprise Value/Revenue
-0.7
Enterprise Value/EBITDA
-1.4
Overview
Shares outstanding
1.65B
Float
639.89M
Shares short
-
% Held by insiders
0.6%
% Held by institutions
0.19%
Average volume (10 days)
27
Average volume (90 days)
45
Price summary
52-Week low
33.02
52-Week high
56.26
Beta
0.6
50-Day moving average
49.55
200-Day moving average
43.63
Dividends and splits
Forward annual dividend rate
1.58
Forward annual dividend yield
0.0353%
Trailing annual dividend rate
1.46
Trailing annual dividend yield
0.0326%
5-Year annual dividend yield
1.73%
Payout ratio
0.46
Dividend Date
4 Jul 2014
Ex-Dividend Date
4 Jun 2014
Last split factor
3:1
Last split Date
29 Jun 2020
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2025
Profitability
Profit margin
0.35%
Operating margin
0.49%
Operational effectiveness
Return on assets
0.16%
Return on equity
0.22%
Income Statement
Revenue (ttm)
6.71B
Revenue per share (ttm)
764.4
Quarterly revenue growth (yoy)
0.15%
Gross profit (ttm)
4.77B
EBITDA
598.01B
Net income to common (ttm)
2.31B
Diluted EPS (ttm)
1.41
Quarterly earnings growth (yoy)
0.4%
Balance Sheet
Total cash (mrq)
5.22B
Total cash per share (mrq)
595.28
Total debt (mrq)
137.1M
Total Debt/Equity (mrq)
1.27
Current ratio (mrq)
4.24%
Book value per share (mrq)
6.56
Cash Flow
Cash flow statement
2.06B
Levered free cash flow (LFCF)
1.4B